Skip to content
Open access

A Comprehensive Study of a New Norfloxacin-Niflumate Hydrate: Structural and Physicochemical Properties, Antibiotic Potency, Anti-Inflammatory Effect, and Drug Safety

Sep 2026 · Molecules · Vol 31, pp. 3189 · 0 citations · 55 references
Medicine

TL;DR

It is demonstrated that a newly formed antibiotic–anti-inflammatory multicomponent system, named norfloxacin–niflumate (NORNIF), in a salt dihydrate form, significantly improved the stability and antibiotic potency of NOR, including against the resistant microbe, as well as the solubility and in vivo anti-inflammatory effect of NIF simultaneously.

Abstract

Multicomponent antibiotic–anti-inflammatory systems have recently attracted considerable attention, as this combination is becoming a standard therapy for infectious diseases. This study aimed to develop a multicomponent system comprising norfloxacin (NOR), an old fluoroquinolone antibiotic, and niflumic acid (NIF), another old, poorly soluble anti-inflammatory drug, to improve the physicochemical properties, antibiotic potency, and anti-inflammation effect, as well as their safety. First, a phase diagram was constructed to ensure solid-state reaction and to predict its stoichiometry; subsequently, the multicomponent system was prepared by solvent-drop grinding. The product was analyzed by a series of thermal analyses and powder X-ray diffraction (PXRD). Next, Fourier-transform infrared spectroscopy and nuclear magnetic resonance elucidated the molecular interactions, and the final 3D structure was determined by single-crystal X-ray diffraction, followed by Hirshfeld surface analysis. Afterward, the solubility and chemical stability were assessed using high-performance liquid chromatography, and the physical stability of the multicomponent system was evaluated by PXRD. Antimicrobial potency against Gram-negative and Gram-positive bacteria, as well as anti-inflammatory activity in vivo, were also evaluated. The results demonstrated that a newly formed antibiotic–anti-inflammatory multicomponent system, named norfloxacin–niflumate (NORNIF), in a salt dihydrate form, significantly improved the stability and antibiotic potency of NOR, including against the resistant microbe, as well as the solubility and in vivo anti-inflammatory effect of NIF simultaneously. In addition, preliminary in silico studies using Swiss-ADME and ProTox-3 predicted that the salt was well absorbed in the gastrointestinal tract and could be classified as toxicity class 4 (non-toxic).

Read PDF

Similar papers

Open access Sep 2026

Novel Azo Sulfonamide Derivatives of 5-Sulfosalicylic Acid: Synthesis, Biological Evaluation, and Computational Profiling

The escalating crisis of multi-drug-resistant pathogens necessitates the development of novel therapeutic scaffolds with enhanced membrane permeability and multi-target inhibitory potential. This study describes the design, synthesis, and mechanistic evaluation of five novel azo-sulfonamide hybrids (4a–e) derived from...

Samar H. Ali, M. El-Zahed, Elham Negm et al. · 0 citations
Open access Sep 2026

Synthesis, X-ray structures and biological evaluation of novel α-aminophosphonate derivatives as anti-inflammatory and antioxidant agents: an integrated in vitro and in silico study

In the field of medicinal chemistry, the design of small molecules is acknowledged as an effective strategy. This study may contribute to the global fight against inflammatory diseases by focusing on the synthesis of novel α-aminophosphonate derivatives incorporating para-aminobenzoic acid (PABA) and benzocaine moietie...

Zoubir Douib, H. K'tir, Haiet Douib et al. · 0 citations
Open access Aug 2026

First Antibacterial Evaluation of an Anthraquinone–triphenylphosphonium Conjugate (SH1) against Sensitive and Drug-resistant Staphylococcus aureus and Escherichia coli

The results identify SH1 as a previously uncharacterised antibacterial agent active against MRSA and support the anthraquinone–DLC pharmacophore as a membrane-active scaffold warranting further structural optimisation.

Victor Arinze Orajekwe · 0 citations
Open access Sep 2026

Synthesis, Characterization and Structural Elucidation of Biocompatible Hydroxychloroquine–Zinc Oxide Hybrid Nanoclusters as Synergistic Antiplasmodial Agents

Background: The increasing emergence of antimalarial drug resistance and safety concerns associated with conventional therapies necessitates the development of improved compounds. In this study, we report the synthesis of hydroxychloroquine–zinc oxide hybrid nanoclusters (HCQ-ZnONPs) by integrating a bioactive organic...

Swati Rani, Balvinder Kumar, J. Devi et al. · 0 citations
Open access Oct 2026

The synthesis of niclosamide derivative as a novel colistin adjuvant for reversing colistin resistance and its antibacterial activity with colistin in vitro

ABSTRACT Colistin (COL) serves as a last-line therapeutic agent against multidrug-resistant gram-negative bacteria (GNB) infections. Nevertheless, widespread clinical use of COL has led to severe bacterial resistance. The anthelmintic drug niclosamide (NIC) has been shown to enhance the activity of COL in combination t...

Pei-Yi Liu, Ying-Biao Li, Fan-Lun Ding et al. · 0 citations
Sep 2026

Drug−Drug Salts of Rucaparib with Nonsteroidal Anti-Inflammatory Drugs: Crystal Structures, Intermolecular Interactions, Solubility Enhancement, and Antitumor Activity

Rucaparib (RUCA) is an orally administered PARP inhibitor with an important clinical value in cancer therapy, but its poor aqueous solubility remains a major challenge for improving its dissolution behavior and pharmaceutical performance. In this study, drug−drug salt formation was adopted to improve the physicochemi...

Can Wang, Shuo Liu, Ji-Yang Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.